FDA STATE_REFERRAL_LETTER - shiraz specialty pharmacy, inc. - May 30, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns shiraz specialty pharmacy, inc. , with an inspection on May 30, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: shiraz specialty pharmacy, inc.
Inspection Date: May 30, 2017
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Steven Saxe
Maria Kelly-doggett

Open in Dashboard

ID · 9e321068-c15a-4197-81fa-fd043af054f2

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.